Sign Up to like & get
recommendations!
0
Published in 2021 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noab090.017
Abstract: Abstract Myc plays a central role in tumorigenesis by orchestrating the expression of genes essential to numerous cellular processes. While it is well established that Myc functions by binding to its target genes to regulate…
read more here.
Keywords:
amplified medulloblastoma;
genome myc;
transcriptional outputs;
myc amplified ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4407
Abstract: Amplification of MYC proto-oncogene is commonly found in many types of cancer, and frequently associated with poor clinical outcomes. Analysis of the TCGA-HNSCC dataset indicates that MYC amplification is estimated to be present in ~12%…
read more here.
Keywords:
myc amplified;
amplification;
hnscc;
cancer ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-523
Abstract: Upregulation of Aurora kinases has been associated with increased tumor progression, and thus they are appealing targets for the development of anti-cancer therapies. In addition to have a critical role in cell cycle regulation, Aurora…
read more here.
Keywords:
aurora kinase;
myc amplified;
kinase;
targeting myc ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.14911
Abstract: Medulloblastoma is comprised of at least four molecular subgroups with distinct clinical outcome (WHO classification 2016). SHH-TP53-mutated as well as MYC-amplified Non-WNT/Non-SHH medulloblastoma show the worst prognosis. Here we present evidence that single application of…
read more here.
Keywords:
pi3k;
shh tp53;
medulloblastoma;
anti neoplastic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051311
Abstract: Simple Summary The oncogene MYC alters cellular metabolism. Medulloblastoma is the most common malignant pediatric brain tumor. MYC-amplified medulloblastoma has a poor prognosis, and the metabolism of MYC-amplified medulloblastoma is poorly understood. We performed comprehensive…
read more here.
Keywords:
myc amplified;
comprehensive metabolic;
brain;
myc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15092525
Abstract: Simple Summary MYC is a well-described oncogene across multiple cancer types. In medulloblastoma (MB), significance is subtype-dependent and associated with a particularly dismal outcome in MYC-amplified group 3 MBs. In our study, we established a…
read more here.
Keywords:
myc amplified;
disease;
amplification;
myc ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncology Reports"
DOI: 10.3892/or.2017.5664
Abstract: Neuroblastoma is a childhood cancer originating from embryonic neural crest cells. Amplification of the proto-oncogene N-myc, seen in ~30% of neuroblastoma tumors, is a marker for poor prognosis. Recently discovered small regulatory RNAs, microRNAs (miRNAs),…
read more here.
Keywords:
specific rna;
neuronal specific;
myc mrna;
myc amplified ... See more keywords